Sunshine Act Meetings
| Published date | 28 January 2022 |
| Citation | 87 FR 4666 |
| Record Number | 2022-01953 |
| Section | Notices |
| Court | Nuclear Regulatory Commission |
4666
Federal Register / Vol. 87, No. 19 / Friday, January 28, 2022 / Notices
•NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publicly
available documents online in the
ADAMS Public Documents collection at
https://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘Begin Web-based ADAMS Search.’’ For
problems with ADAMS, please contact
the NRC’s Public Document Room (PDR)
reference staff at 1–800–397–4209, 301–
415–4737, or by email to
PDR.Resource@nrc.gov. For the
convenience of the reader, instructions
about obtaining materials referenced in
this document are provided in the
‘‘Availability of Documents’’ section.
•NRC’s PDR: You may examine and
purchase copies of public documents,
by appointment, at the NRC’s PDR,
Room P1 B35, One White Flint North,
11555 Rockville Pike, Rockville,
Maryland 20852. To make an
appointment to visit the PDR, please
send an email to PDR.Resource@nrc.gov
or call 1–800–397–4209 or 301–415–
4737, between 8:00 a.m. and 4:00 p.m.
(ET), Monday through Friday, except
Federal holidays.
FOR FURTHER INFORMATION CONTACT
:
George Alexander, Office of Nuclear
Material Safety and Safeguards, U.S.
Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–6755; email:
George.Alexander@nrc.gov.
SUPPLEMENTARY INFORMATION
:
I. Background
The Sigma-Aldrich Company’s
(Sigma’s) Fort Mims Site is located at
11542 Fort Mims Drive, Maryland
Heights, Missouri in a commercial/
industrial park. The site consists of a 3-
acre parcel of land previously used for
the radiolabeling of chemicals with
carbon-14 and tritium.
II. Discussion
By email dated August 22, 2019, the
NRC received an application to amend
Sigma’s decommissioning plan. That
application was supplemented by letter
dated April 27, 2020, requesting a
license amendment for the termination
of NRC Materials License No. 24–
16273–01, and by letter dated October
19, 2020, providing the NRC Form 313
‘‘Application for Materials License’’ for
this action. By email dated July 31,
2020, the NRC staff accepted for
detailed technical review Sigma’s
license amendment request to amend
the decommissioning plan and
terminate the license.
The NRC staff reviewed the revised
decommissioning plan with the site-
specific dose model and license
termination request. Based on Sigma’s
dose analysis and the NRC’s
independent and confirmatory surveys
and analyses, the NRC staff concluded
in a safety evaluation report dated
November 16, 2021, that the Fort Mims
Site met the dose criteria for
unrestricted use and that the residual
radioactivity is as low as reasonably
achievable, consistent with section
20.1402 of title 10 of the Code of Federal
Regulations, ‘‘Radiological criteria for
unrestricted use.’’ Based on an
environmental assessment dated
November 12, 2021, NRC staff
concluded that there would be no
significant environmental impacts.
Accordingly, NRC Materials License No.
24–16273–01 for the Fort Mims Site was
terminated.
III. Availability of Documents
The documents identified in the
following table are available to
interested persons through ADAMS, as
indicated.
Document ADAMS
accession No.
NRC Approval of Sigma-Aldrich Company’s Fort Mims Facility Decommissioning Plan, dated May 12, 2009 ............................. ML091330309
Sigma-Aldrich Fort Mims Site Revised Decommissioning Plan, dated June 27, 2019 ................................................................... ML19273A160
Transmittal Email—Sigma-Aldrich Fort Mims Revised Decommissioning Plan, dated August 22, 2019 ....................................... ML19273A163
Sigma-Aldrich Fort Mims Site Request for License Termination, dated April 27, 2020 .................................................................. ML20120A544
Transmittal Email—NRC Acceptance Review of Revised Decommissioning Plan and License Termination Request, dated July
31, 2020. ML20213C693
Sigma-Aldrich Fort Mims Site Revised Decommissioning Plan: NRC Form 313, ‘‘Application for Materials License,’’ dated Oc-
tober 19, 2020. ML20294A191
NRC Environmental Assessment and Finding of No Significant Impact Related to the Issuance of a License Amendment for
the Sigma-Aldrich Fort Mims Site, dated November 12, 2021. ML21277A097
NRC Safety Evaluation Report of Revised Decommissioning Plan and License Termination Request for the Sigma-Aldrich
Fort Mims Site, dated November 16, 2021. ML21300A384
NRC Materials License 24–16273–01 Termination Amendment 21, dated November 16, 2021 ................................................... ML21300A383
Dated: January 25, 2022.
For the Nuclear Regulatory Commission.
Randolph W. Von Till,
Chief, Uranium Recovery and Materials
Decommissioning Branch, Division of
Decommissioning, Uranium Recovery and
Waste Programs, Office of Nuclear Material
Safety and Safeguards.
[FR Doc. 2022–01754 Filed 1–27–22; 8:45 am]
BILLING CODE 7590–01–P
NUCLEAR REGULATORY
COMMISSION
[NRC–2022–0001]
Sunshine Act Meetings
TIME AND DATE
: Weeks of January 31,
February 7, 14, 21, 28, March 7, 2022.
PLACE
: Commissioners’ Conference
Room, 11555 Rockville Pike, Rockville,
Maryland.
STATUS
: Public.
Week of January 31, 2022
There are no meetings scheduled for
the week of January 31, 2022.
Week of February 7, 2022—Tentative
Tuesday, February 8, 2022
10:00 a.m. Meeting with the
Organization of Agreement States
and the Conference of Radiation
Control Program Directors (Public
Meeting); (Contact: Celimar
Valentin-Rodriguez: 301–415–
7124).
Additional Information: The public is
invited to attend the Commission’s
meeting live by webcast at the Web
address—https://video.nrc.gov/. For
those who would like to attend in
person, note that all visitors are required
to complete the NRC Self-Health
Assessment and Certification of
Vaccination forms. Visitors who certify
VerDate Sep<11>2014 18:03 Jan 27, 2022 Jkt 256001 PO 00000 Frm 00115 Fmt 4703 Sfmt 4703 E:\FR\FM\28JAN1.SGM 28JAN1
jspears on DSK121TN23PROD with NOTICES1
4667
Federal Register / Vol. 87, No. 19 / Friday, January 28, 2022 / Notices
that they are not fully vaccinated or
decline to complete the certification
must have proof of a negative Food and
Drug Administration-approved
polymerase chain reaction (PCR) or
Antigen (including rapid tests) COVID–
19 test specimen collection from no
later than the previous 3 days prior to
entry to an NRC facility. The forms and
additional information can be found
here https://www.nrc.gov/about-nrc/
covid-19/guidance-for-visitors-to-nrc-
facilities.pdf.
Week of February 14, 2022—Tentative
There are no meetings scheduled for
the week of February 14, 2022.
Week of February 21, 2022—Tentative
Thursday, February 24, 2022
10:00 a.m. Briefing on Regulatory
Research Program Activities (Public
Meeting); (Contact: Nick
Difrancesco: 301–415–1115).
Additional Information: The public is
invited to attend the Commission’s
meeting live by webcast at the Web
address—https://video.nrc.gov/. For
those who would like to attend in
person, note that all visitors are required
to complete the NRC Self-Health
Assessment and Certification of
Vaccination forms. Visitors who certify
that they are not fully vaccinated or
decline to complete the certification
must have proof of a negative Food and
Drug Administration-approved
polymerase chain reaction (PCR) or
Antigen (including rapid tests) COVID–
19 test specimen collection from no
later than the previous 3 days prior to
entry to an NRC facility. The forms and
additional information can be found
here https://www.nrc.gov/about-nrc/
covid-19/guidance-for-visitors-to-nrc-
facilities.pdf.
Week of February 28, 2022—Tentative
There are no meetings scheduled for
the week of February 28, 2022.
Week of March 7, 2022—Tentative
There are no meetings scheduled for
the week of March 7, 2022.
CONTACT PERSON FOR MORE INFORMATION
:
For more information or to verify the
status of meetings, contact Wesley Held
at 301–287–3591 or via email at
Wesley.Held@nrc.gov. The schedule for
Commission meetings is subject to
change on short notice.
The NRC Commission Meeting
Schedule can be found on the internet
at: https://www.nrc.gov/public-involve/
public-meetings/schedule.html.
The NRC provides reasonable
accommodation to individuals with
disabilities where appropriate. If you
need a reasonable accommodation to
participate in these public meetings or
need this meeting notice or the
transcript or other information from the
public meetings in another format (e.g.,
braille, large print), please notify Anne
Silk, NRC Disability Program Specialist,
at 301–287–0745, by videophone at
240–428–3217, or by email at
Anne.Silk@nrc.gov. Determinations on
requests for reasonable accommodation
will be made on a case-by-case basis.
Members of the public may request to
receive this information electronically.
If you would like to be added to the
distribution, please contact the Nuclear
Regulatory Commission, Office of the
Secretary, Washington, DC 20555, at
301–415–1969, or by email at
Tyesha.Bush@nrc.gov or Betty.Thweatt@
nrc.gov.
The NRC is holding the meetings
under the authority of the Government
in the Sunshine Act, 5 U.S.C. 552b.
Dated: January 26, 2022.
For the Nuclear Regulatory Commission.
Wesley W. Held,
Policy Coordinator, Office of the Secretary.
[FR Doc. 2022–01953 Filed 1–26–22; 4:15 pm]
BILLING CODE 7590–01–P
PENSION BENEFIT GUARANTY
CORPORATION
Proposed Submission of Information
Collection for OMB Review; Comment
Request; Medical Exception Request
AGENCY
: Pension Benefit Guaranty
Corporation.
ACTION
: Notice of intent to request
extension of OMB approval of
information collection.
SUMMARY
: The Pension Benefit Guaranty
Corporation (PBGC) intends to request
that the Office of Management and
Budget (OMB) extend approval, without
change, under the Paperwork Reduction
Act, of a collection of information for its
employees to request a medical
exception to the COVID–19 vaccination
requirement.
DATES
: Comments must be submitted on
or before March 29, 2022.
ADDRESSES
: Comments may be
submitted by any of the following
methods:
•Federal eRulemaking Portal: http://
www.regulations.gov. Follow the
instructions for submitting comments.
•Email: paperwork.comments@
pbgc.gov. Refer to OMB control number
1212–0075 in the subject line.
•Mail or Hand Delivery: Regulatory
Affairs Division, Office of the General
Counsel, Pension Benefit Guaranty
Corporation, 1200 K Street NW,
Washington, DC 20005–4026.
Commenters are strongly encouraged
to submit public comments
electronically. PBGC expects to have
limited personnel available to process
public comments that are submitted on
paper through mail. Until further notice,
any comments submitted on paper will
be considered to the extent practicable.
All submissions received must
include the agency’s name (Pension
Benefit Guaranty Corporation, or PBGC)
and refer to OMB control number 1212–
0075. All comments received will be
posted without change to PBGC’s
website, http://www.pbgc.gov, including
any personal information provided.
Commenters should not include any
information for which disclosure is
restricted by statute, such as trade
secrets and commercial or financial
information (‘‘confidential business
information’’). Submission of
confidential business information
without a request for protected
treatment constitutes a waiver of any
claims of confidentiality.
Copies of the collection of
information may be obtained by writing
to Disclosure Division, Office of the
General Counsel, Pension Benefit
Guaranty Corporation, 1200 K Street
NW, Washington, DC 20005–4026, or
calling 202–229–4040 during normal
business hours. TTY users may call the
Federal Relay Service toll-free at 800–
877–8339 and ask to be connected to
202–229–4040.
FOR FURTHER INFORMATION CONTACT
:
Melissa Rifkin (rifkin.melissa@
pbgc.gov), Attorney, Regulatory Affairs
Division, Office of the General Counsel,
Pension Benefit Guaranty Corporation,
1200 K Street NW, Washington, DC
20005–4026; 202–229–6563. (TTY and
TDD users may call the Federal relay
service toll-free at 800–877–8339 and
ask to be connected to 202–229–6563.)
SUPPLEMENTARY INFORMATION
: Under
Executive Order 14043, every Federal
agency must ‘‘implement, to the extent
consistent with applicable law, a
program to require COVID–19
vaccination for all of its Federal
employees, with exceptions only as
required by law.’’ In following this
directive, the Pension Benefit Guaranty
Corporation (PBGC) has a requirement
that its employees must receive and
submit proof of a COVID–19
vaccination. As required by 29 U.S.C.
701 et seq. and 29 CFR part 1630, PBGC
allows an exception from the
vaccination requirement for employees
who demonstrate medical reasons or
disabilities that would make the
COVID–19 vaccine unsafe for them. To
VerDate Sep<11>2014 18:03 Jan 27, 2022 Jkt 256001 PO 00000 Frm 00116 Fmt 4703 Sfmt 4703 E:\FR\FM\28JAN1.SGM 28JAN1
jspears on DSK121TN23PROD with NOTICES1
